These data suggest that the reduction in MYB levels is part of the normal pathway of differentiation of mammary epithelial cells, and validate the use of mammary carcinoma cell lines and MECs as models to study the role of MYB in this process. The gene discussed is MYB; the disease is breast carcinoma.